Drug Trial Radar · NCT04380519
Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)
Last checked: Nov 20, 2026Latest source record: Jan 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
372
Actual
Start
Apr 23, 2020
Primary completion
Jul 10, 2020
Study completion Jul 24, 2020
Sponsor
- Lead sponsor
- R-Pharm International, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Data Management 365; K-Research, LLC
- First posted
- May 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study was to evaluate the efficacy and safety of a single dose of RPH-104 (80 mg) or OKZ (64 mg) compared to placebo in addition to standard therapy in patients with severe SARS-CoV-2 infection (COVID-19) at Day 15 of the study.
Conditions
- COVID-19
Interventions
RPH-104 80 mgDrug
solution for subcutaneous administration 40 mg/mL, 2 mL in the 4-mL glass vial
Olokizumab 64 mgDrug
solution for subcutaneous administration 160 mg/mL, in the 2-mL glass vial (target volume 0,4 ml)
PlaceboDrug
Normal Saline (0.9% Sodium Chloride solution for Injection), in the market package
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Responders in Each Treatment GroupTime frame: Day 15
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Private healthcare institution "Clinical Hospital" Russian Railways-Medicine named after N. A. Semashko"
Moscow, Russia
State Budget Healthcare Institution "City Clinical Hospital № 15 named after O.M. Filatov" of Moscow City Healthcare Department
Moscow, Russia
Federal State Budgetary Institution "Federal Center for Cerebrovascular Pathology and Stroke" of the Ministry of Health of the Russian Federation
Moscow, Russia
Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University)
Moscow, Russia
Federal State Autonomous Education Institution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of the Russian Federation (Sechenov University)
Moscow, Russia
Federal State Budgetary Institution "Central Clinical Hospital with Polyclinic" of Administrative Directorate of the President of the Russian Federation
Moscow, Russia
Federal State Budget Institution "National Medicine Research Center on Cardiology" By Ministry of Healthcare of Russian Federation
Moscow, Russia
State Budget Institution of Healthcare "City Clinical Hospital #52", Moscow City Healthcare Department
Moscow, Russia
State budgetary healthcare institution City Clinical Hospital named after S.I. Spasokukotsky Department of Health of the city of Moscow City Clinical Hospital No. 50
Moscow, Russia
Moscow State Budget Institution of Healthcare "Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare"
Moscow, Russia
АО "State Company "Medsi" based on Clinical Hospital №1"
Moscow, Russia
Federal State Budgetary Educational Institution of Higher Education "Volga Research Medical University" of the Ministry of Health of the Russian Federation
Nizhny Novgorod, Russia
Federal Budgetary State Healthcare Institution "National Medical Research Center named after B.A. Almazov"
Saint Petersburg, Russia
Saint-Petersburg State Budget Institution of Healthcare "City Hospital №40"
Saint Petersburg, Russia
Budgetary Health Institution Voronezh Regional Clinical Hospital №1
Voronezh, Russia
State Budget Healthcare Institution of Yaroslavl Region "Yaroslavl Region Clinical Hospital of War Veterans"
Yaroslavl, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.